Related Experiment Video

Updated: May 20, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

[Prevention and treatment of atherosclerosis and cardiovascular diseases]

Hilla Knobler1, Rafael Bitzur, Dov Gavish

  • 1Unit of Diabetes & Metabolic Diseases, Kaplan Medical Center, Rehovot. Knobler@inter.net.il

Harefuah
|August 1, 2012
PubMed

Insights

Updated guidelines for preventing and treating atherosclerosis in Israel are now available, incorporating new scientific evidence. These recommendations address cardiovascular risk, smoking cessation, and dyslipidemia management for better patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Medical Guidelines

Context:

  • Atherosclerosis is a leading cause of global morbidity and mortality, significantly impacting Israel.
  • Previous guidelines from the Israeli Society for Research, Prevention and Treatment of Atherosclerosis were published in 2005.
  • Recent scientific advancements necessitate an update to current prevention and treatment strategies.

Purpose:

  • To provide updated, evidence-based recommendations for the prevention and treatment of atherosclerosis in Israel.
  • To incorporate new scientific data into clinical practice guidelines.
  • To address the specific needs of the Israeli healthcare system.

Summary:

  • These guidelines present updated recommendations on cardiovascular risk assessment, smoking cessation, and dyslipidemia treatment.
  • They are a collaborative effort between multiple Israeli medical societies.
  • The recommendations consider international guidelines and local healthcare requirements.

Impact:

  • Aims to improve the management of atherosclerosis, reducing associated morbidity and mortality in Israel.
  • Facilitates the integration of the latest scientific findings into clinical practice.
  • Provides a framework for healthcare professionals to optimize patient care for atherosclerosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...